Health Care · Services-Home Health Care Services · Nasdaq · CIK 1832332 · FYE Jan 1 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $9.69Day −0.62%Mkt cap $2.1B1Y +142.9%Off 52W high −6.1%Vol (1Y) 67.6%
Daily closing price, split-adjusted to the current basis; 3y shown of 943 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Fair value (model)$10.24 |
| Implied upside+5.7% |
| Valuation confidenceLOW |
| Price impliesUNDEMANDING · 7.7% growth |
| Short interest2.1% of sh out |
| Days to cover2.0d |
| 13F net flow (QoQ)+0.93% |
| Top-10 13F concentration78.4% |
| Next report (est.)2026-08-13 |
Fair value, confidence and the reverse-DCF grade are the MATERIALIZED daily snapshot (the same columns the screener serves), not a live model run. Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$2.52B |
| Earnings (TTM)$261.5M |
| YTD+18.6% |
| 1Y+142.9% |
| 3Y+460.1% |
| Since incept. (ann.)+66.8% |
Total return through 2026-07-30 · series begins 2022-10-18. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)67.6% |
| Ann. volatility (3Y)74.1% |
| Sharpe (1Y)1.62 |
| Sharpe (3Y)1.13 |
| Max drawdown (1Y)−39.4% |
| Max drawdown (3Y)−40.8% |
| Beta (3Y vs SPY)2.59 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Bain Capital Investors LLC | 81.6M | $526M | 37.52% | +0.0% |
| J.H. Whitney Equity Partners VII, LLC | 36.2M | $233M | 16.66% | +0.0% |
| Nut Tree Capital Management, LP | 12.9M | $83M | 5.94% | +4.4% |
| BlackRock, Inc. | 5.5M | $35M | 2.53% | −10.7% |
| SUMMIT PARTNERS L P | 5.5M | $35M | 2.51% | −27.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.0M | $26M | 1.83% | new |
| Boston Partners | 2.8M | $18M | 1.30% | +756.0% |
| BRAIDWELL LP | 2.2M | $14M | 1.01% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-04-04 | 2026-05-14 | $0.19 | +533.3% | $647.9M | +15.9% |
| 2026-01-03 | 2026-03-19 | — | — | $662.5M | +27.4% |
| 2025-09-27 | 2025-11-06 | $0.06 | — | $621.9M | +22.2% |
| 2025-06-28 | 2025-08-07 | $0.13 | +85.7% | $589.6M | +16.8% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Private Duty Services 82% · Home Health And Hospice 10% · Medical Solutions 8%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
| Net margin9.2% |
| ROIC21.6% |
| Debt / equity6.68× |
| Total debt / EBITDA4.87× |
| Sales growth 3Y10.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
